ESMO Virtual Preceptorship on Hereditary Cancer Genetics 2021
Discover the multidisciplinary management, standards of care and future perspectives of hereditary cancer genetics
Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.
MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23
The leading professional organisation for medical oncology
Access the latest resources available on the portal
Submit your original scientific data to our monthly worldwide presentations!
Read our interviews with KOLs in oncology on the future of real-world research, the promises of cancer vaccines and the ESMO's commitment to cancer prevention.
Discover the multidisciplinary management, standards of care and future perspectives of hereditary cancer genetics
The ESMO-MCBS is a validated and reproducible tool to assess the magnitude of clinical benefit for cancer medicines.
Substantial antitumour activity observed with idecabtagene vicleucel in the KarMMa study
Twice daily poziotinib dosing improved the adverse event profile; early results showed retained anti-tumour activity
Clinical benefit of FGFR inhibition is stronger in patients with an FGFR fusion or mutation compared to FGFR amplification
Endogenous and exogenous mutational processes driven by abnormal DNA editing, mutagens or age-related DNA alterations over the history of a malignant tumour provide an individual tumour signature
ESMO would like to thank the Iranian Society of Medical Oncology and Hematology (ISMOH) for providing translation in Persian language
This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.
For more detailed information on the cookies we use, please check our Privacy Policy.
Necessary cookies enable core functionality. The website cannot function properly without these cookies, and can only be disabled by changing your browser preferences.